Cargando…

Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells

SIMPLE SUMMARY: The poor prognoses of patients with glioblastoma multiforme (GBM) are attributed to glioblastoma stem-like cells (GSCs), which induce drug resistance and rapid tumor recurrence. Accordingly, the discovery of promising therapies targeting GSCs is important for the treatment of GBM. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jang Mi, Kim, Yu Jin, Jung, Hye Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909660/
https://www.ncbi.nlm.nih.gov/pubmed/35267623
http://dx.doi.org/10.3390/cancers14051315